학술논문
The GIRAFE phase II trial on MVCT-based “volumes of the day” and “dose of the day” addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer
Document Type
Article
Author
Source
In: Clinical and Translational Radiation Oncology . (Clinical and Translational Radiation Oncology, May 2019, 16:34-39)
Subject
Language
English
ISSN
24056308